Carbon dioxide-angiography for patients with peripheral arterial disease at risk of contrast-induced nephropathy

doi:10.4330/wjc.v12.i2.76

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9431)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

413

WORD

199

HTML

6250

Figures (1-3)

480

Tables (1-3)

334

Sum=7676

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

796

Download

959

Sum=1755

Feb 26, 2020 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Cardiol. Feb 26, 2020; 12(2): 76-90
Published online Feb 26, 2020. doi: 10.4330/wjc.v12.i2.76

Full Size Figure Download Figure

Figure 3 Average contrast used per endovascular procedure. Data from our Office Based Lab shows a reduction in Total Iodine Contrast used per procedure after adopting Hybrid CO₂ Angiography.

Citation: Gupta A, Dosekun AK, Kumar V. Carbon dioxide-angiography for patients with peripheral arterial disease at risk of contrast-induced nephropathy. World J Cardiol 2020; 12(2): 76-90
URL: https://www.wjgnet.com/1949-8462/full/v12/i2/76.htm
DOI: https://dx.doi.org/10.4330/wjc.v12.i2.76